In reply to 'discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome'
- PMID: 25616633
- DOI: 10.1053/j.ajkd.2014.05.028
In reply to 'discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome'
Comment on
-
Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases.Am J Kidney Dis. 2014 Oct;64(4):633-7. doi: 10.1053/j.ajkd.2014.01.434. Epub 2014 Mar 19. Am J Kidney Dis. 2014. PMID: 24656451
-
Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome.Am J Kidney Dis. 2015 Feb;65(2):342. doi: 10.1053/j.ajkd.2014.04.039. Am J Kidney Dis. 2015. PMID: 25616634 No abstract available.